Split- versus single-dose preparation tolerability in a multiethnic population: decreased side effects but greater social barriers

Authors Gabriel Perreault, Adam Goodman, Sebastian Larion, Ahana Sen, Kirsten Quiles, Michael Poles, Renee Williams.

Abstract

Background This study was performed to compare patient-reported tolerability and its barriers in single- vs. split-dose 4-L polyethylene glycol (PEG) bowel preparation for colonoscopy in a large multiethnic, safety-net patient population.


Methods A cross-sectional, dual-center study using a multi-language survey was used to collect patient-reported demographic, medical, socioeconomic, and tolerability data from patients undergoing outpatient colonoscopy. Univariate and multivariate analyses were used to identify demographic and clinical factors significantly associated with patient-reported bowel preparation tolerability.


Results A total of 1023 complete surveys were included, of which 342 (33.4%) completed singledose and 681 (66.6%) split-dose bowel preparation. Thirty-nine percent of the patients were Hispanic, 50% had Medicaid or no insurance, and 34% had limited English proficiency. Patients who underwent split-dose preparation were significantly more likely to report a tolerable preparation, with less severe symptoms, than were patients who underwent single-dose preparation. Multiple logistic regression revealed that male sex and instructions in the preferred language were associated with tolerability of the single-dose preparation, while male sex and concerns about medications were associated with tolerability of the split-dose preparation.


Conclusions In a large multiethnic safety-net population, split-dose bowel preparation was significantly more tolerable and associated with less severe gastrointestinal symptoms than singledose preparation. The tolerability of split-dose bowel preparation was associated with social barriers, including concerns about interfering with other medications.


Keywords Colonoscopy, bowel preparation, single-dose, split-dose, tolerability, safety-net


Ann Gastroenterol 2018; 31 (3): 356-364

Published
2018-05-02
Section
Original Articles